Previous studies reveal a decrease in EIF4E3 expression increases tumor cell activity and aggressiveness in the head, and neck squamous cell carcinomas, acute myeloid leukemia, and breast cancer45–47. Here, EIF4E3 is linked to acute myeloid leukemia.